絞り込み

17424

広告

次世代暗号技術「量子暗号通信」大規模開発プロジェクト始動へ (NHK)

「量子暗号通信」と呼ばれる次世代の暗号技術の世界展開を目指して、大手企業や大学などが参加する大がかりな開発プロジェクトが、今月始まることが分かりました。 インタ...

  1. 新型コロナ 九州豪雨被災支援の高松市職員...
  2. 新型コロナ WHO先遣隊が北京到着し協議...
  3. 中国すす排出 10年間で35%減 海洋研...
  4. 新型コロナ 感染拡大、国と都責任転嫁 菅...

ニュース一覧

「"Yee MK "[Author]」の検索結果

44件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Longitudinal Assessment of Health Symptoms in Relation to Neurotoxicant Exposures in 1991 Gulf War Veterans: The Ft. Devens Cohort.

Machine learning to predict venous thrombosis in acutely ill medical patients.

Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial).

A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial.

Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.

Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.

Rates of Chronic Medical Conditions in 1991 Gulf War Veterans Compared to the General Population.

Most Promising Therapies in Interventional Cardiology.

Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction.

Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.

Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.

The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.

Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial.

Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism.

D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy).

SECURE PCI: how important can a subgroup analysis be?

Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.

Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります